ACM
ALPN

Altium Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Altium Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-77,848
Closed -$3.09M – 84
2024
Q1 		$3.09M Sell
77,848
-875
-1% -$25.8K 1.22% 28
2023
Q4 		$1.5M Buy
+78,723
New +$1.09M 1.02% 25

Altium Capital Management's ALPN Position: Q2 2024 in Review

Altium Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 77,848 shares — an estimated $3.09M sold.

Altium Capital Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $3.09M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Altium Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Altium Capital Management sold 77,848 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $3.09M.
  • Altium Capital Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • Altium Capital Management's Alpine Immune Sciences Inc position peaked at $3.09M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.